ZA200210278B - 3-azabicyclo(3.1.0)hexane derivatives useful in therapy. - Google Patents

3-azabicyclo(3.1.0)hexane derivatives useful in therapy.

Info

Publication number
ZA200210278B
ZA200210278B ZA200210278A ZA200210278A ZA200210278B ZA 200210278 B ZA200210278 B ZA 200210278B ZA 200210278 A ZA200210278 A ZA 200210278A ZA 200210278 A ZA200210278 A ZA 200210278A ZA 200210278 B ZA200210278 B ZA 200210278B
Authority
ZA
South Africa
Prior art keywords
azabicyclo
therapy
derivatives useful
hexane derivatives
hexane
Prior art date
Application number
ZA200210278A
Other languages
English (en)
Inventor
Bernard Joseph Banks
Douglas James Critcher
Ashley Edward Fenwick
Morris David Gethin
Stephen Paul Gibson
Graham Lunn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200210278B publication Critical patent/ZA200210278B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200210278A 2000-06-23 2002-12-19 3-azabicyclo(3.1.0)hexane derivatives useful in therapy. ZA200210278B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015562.2A GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles

Publications (1)

Publication Number Publication Date
ZA200210278B true ZA200210278B (en) 2003-12-19

Family

ID=9894368

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200210278A ZA200210278B (en) 2000-06-23 2002-12-19 3-azabicyclo(3.1.0)hexane derivatives useful in therapy.

Country Status (34)

Country Link
EP (1) EP1292574A1 (xx)
JP (1) JP2004512263A (xx)
KR (1) KR20040002386A (xx)
CN (1) CN1639121A (xx)
AP (1) AP2002002698A0 (xx)
AR (1) AR028969A1 (xx)
AU (1) AU781837B2 (xx)
BG (1) BG107329A (xx)
BR (1) BR0111867A (xx)
CA (1) CA2412188A1 (xx)
CZ (1) CZ20023967A3 (xx)
DO (1) DOP2001000187A (xx)
DZ (1) DZ3368A1 (xx)
EA (1) EA005117B1 (xx)
GB (1) GB0015562D0 (xx)
HR (1) HRP20020998A2 (xx)
HU (1) HUP0301228A3 (xx)
IL (1) IL153427A0 (xx)
IS (1) IS6637A (xx)
MA (1) MA26915A1 (xx)
MX (1) MXPA02012878A (xx)
NO (1) NO20026168L (xx)
NZ (1) NZ523141A (xx)
OA (1) OA12293A (xx)
PA (1) PA8519401A1 (xx)
PE (1) PE20020253A1 (xx)
PL (1) PL365956A1 (xx)
SK (1) SK17172002A3 (xx)
TN (1) TNSN01094A1 (xx)
UA (1) UA73176C2 (xx)
UY (1) UY26787A1 (xx)
WO (1) WO2001098267A1 (xx)
YU (1) YU91802A (xx)
ZA (1) ZA200210278B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1440059E (pt) * 2001-10-22 2008-05-16 Pfizer Prod Inc Derivados do 3-azabiciclo(3.1.0)hexano como antagonistas de receptores opióides
ES2325782T3 (es) * 2002-05-17 2009-09-17 Tioga Pharmaceuticals, Inc. Empleo de compuestos efectivos como moduladores selectivos de receptores de opiaceos.
DE10259245A1 (de) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
BRPI0507945A (pt) * 2004-02-23 2007-07-24 Glaxo Group Ltd derivados de azabiciclo (3.1.0) hexano utilizáveis como moduladores de receptores d3 de dopamina
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE484502T1 (de) * 2005-06-14 2010-10-15 Glaxo Group Ltd Neue verbindungen
EP2010518B1 (en) * 2006-04-03 2011-02-16 Glaxo Group Limited Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors
KR101208326B1 (ko) 2007-03-30 2012-12-05 티오가 파마슈티칼스, 인코포레이티드 설사-우세형 및 교대형 과민성 장 증후군의 치료를 위한 카파-아편제 작용제
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
JP5736040B2 (ja) * 2010-06-11 2015-06-17 ローズ テクノロジーズ Ｎ−アリル化合物の調製のための遷移金属触媒プロセスおよびその使用
US9133116B2 (en) 2010-09-28 2015-09-15 Panacea Biotec Ltd. Bicyclic compounds
WO2015076310A1 (ja) * 2013-11-20 2015-05-28 株式会社 三和化学研究所 新規３－アザビシクロ［３．１．０］ヘキサン誘導体及びその医薬用途
CA2985327A1 (en) 2015-05-20 2016-11-24 Sanwa Kagaku Kenkyusho Co., Ltd. Crystal of salt of 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof
BR112019016775A2 (pt) 2017-02-17 2020-03-31 Trevena, Inc. Compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 7 membros, métodos de uso e produção dos mesmos
BR112019016827A2 (pt) * 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
JPWO2018159716A1 (ja) 2017-03-02 2019-12-26 株式会社三和化学研究所 アルコール使用障害の治療薬
CN108250088B (zh) * 2018-01-04 2020-10-30 四川之江高新材料股份有限公司 N，n，n′-三甲基-n′-羟乙基双氨基乙基醚的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065230A (en) * 1959-03-16 1962-11-20 Burroughs Wellcome Co Azabicyclohexanes and method of preparing them
AR245933A1 (es) * 1987-04-16 1994-03-30 Lilly Co Eli Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales.
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
PE20001420A1 (es) * 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy

Also Published As

Publication number Publication date
UY26787A1 (es) 2002-01-31
PA8519401A1 (es) 2002-12-30
SK17172002A3 (sk) 2004-09-08
EA200201269A1 (ru) 2003-06-26
HUP0301228A2 (hu) 2003-08-28
IL153427A0 (en) 2003-07-06
EP1292574A1 (en) 2003-03-19
IS6637A (is) 2002-11-28
BG107329A (en) 2003-07-31
MXPA02012878A (es) 2003-05-14
KR20040002386A (ko) 2004-01-07
NO20026168D0 (no) 2002-12-20
BR0111867A (pt) 2003-07-01
TNSN01094A1 (fr) 2005-11-10
NO20026168L (no) 2003-02-18
PL365956A1 (en) 2005-01-24
CZ20023967A3 (cs) 2004-02-18
HUP0301228A3 (en) 2005-08-29
UA73176C2 (en) 2005-06-15
AU6259101A (en) 2002-01-02
MA26915A1 (fr) 2004-12-20
HRP20020998A2 (en) 2004-02-29
OA12293A (en) 2004-03-18
WO2001098267A1 (en) 2001-12-27
PE20020253A1 (es) 2002-04-08
AP2002002698A0 (en) 2002-12-31
AR028969A1 (es) 2003-05-28
CA2412188A1 (en) 2001-12-27
YU91802A (sh) 2006-05-25
JP2004512263A (ja) 2004-04-22
NZ523141A (en) 2005-06-24
CN1639121A (zh) 2005-07-13
DOP2001000187A (es) 2002-03-30
GB0015562D0 (en) 2000-08-16
EA005117B1 (ru) 2004-10-28
WO2001098267A8 (en) 2003-02-27
AU781837B2 (en) 2005-06-16
DZ3368A1 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
TW539393U (en) 089204149
AU2001252135A1 (en) Therapeutic agents
IL159890A0 (en) Dolastatin 10 derivatives
GB0016787D0 (en) Compounds useful in therapy
ZA200210278B (en) 3-azabicyclo(3.1.0)hexane derivatives useful in therapy.
SG97205A1 (en) Super-halo formation in fet's
MXPA03000644A (es) Nuevos derivados de indol y uso como medicamentos.
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
IL154675A0 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
AU2001266939A1 (en) Biocidal polyamides and methods
MXPA01011743A (es) Arilpirimidinas substituidas 5-.
AU2001273903A1 (en) Therapeutic agents
GB0104243D0 (en) Floodstoppers 2
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
GB9916299D0 (en) Dogex 1
AU2001296307A1 (en) 55054, a human metalloprotease and uses therefor
GB0014046D0 (en) Compounds useful in therapy
GB0007203D0 (en) Supertrowel 2000
GB0031770D0 (en) Coffins
AU2001294910A1 (en) 3-thioxo-(1,2,4)-oxadiazinan-5-one and their use as anti-antherosclerotic agents
AUPQ417599A0 (en) Legs 11
GB0028459D0 (en) Glor 2
HK1045506A1 (en) Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods
AU2001285370A1 (en) 50566, human glyoxalase ii related factor and uses thereof